Pathophysiology, Others.


Last updated: 2021 Oct 31
Total hit(s): 1
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
Rhesus macaques were immunised with the BBIBP-CorV vaccine at low dose (2ug/dose) and high dose (8ug/dose). exposure to SARS-CoV-2 virus protected the immunised rhesus macaques.
32778225
(Cell)
PMID
32778225
Date of Publishing: 2020 Aug 6
Title Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
Author(s) nameWang H, Zhang Y et al.
Journal Cell
Impact factor
27.35
Citation count: 50
Date of Entry 2021 Oct 31